Literature DB >> 25645281

Trafficking and degradation pathways in pathogenic conversion of prions and prion-like proteins in neurodegenerative diseases.

Guiliana Soraya Victoria1, Chiara Zurzolo2.   

Abstract

Several neurodegenerative diseases such as transmissible spongiform encephalopathies, Alzheimer's and Parkinson's diseases are caused by the conversion of cellular proteins to a pathogenic conformer. Despite differences in the primary structure and subcellular localization of these proteins, which include the prion protein, α-synuclein and amyloid precursor protein (APP), striking similarity has been observed in their ability to seed and convert naïve protein molecules as well as transfer between cells. This review aims to cover what is known about the intracellular trafficking of these proteins as well as their degradation mechanisms and highlight similarities in their movement through the endocytic pathway that could contribute to the pathogenic conversion and seeding of these proteins which underlies the basis of these diseases.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Conversion; Degradation; Prion; Prion-like; Seeding; Trafficking

Mesh:

Substances:

Year:  2015        PMID: 25645281     DOI: 10.1016/j.virusres.2015.01.019

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  8 in total

Review 1.  Cholesterol and its reciprocal association with prion infection.

Authors:  Jessica Cashion; Wanzhen Zhang; Tahir Ali; Sabine Gilch
Journal:  Cell Tissue Res       Date:  2022-07-12       Impact factor: 4.051

2.  Limited ER quality control for GPI-anchored proteins.

Authors:  Natalia Sikorska; Leticia Lemus; Auxiliadora Aguilera-Romero; Javier Manzano-Lopez; Howard Riezman; Manuel Muñiz; Veit Goder
Journal:  J Cell Biol       Date:  2016-06-20       Impact factor: 10.539

3.  Regulation of sub-compartmental targeting and folding properties of the Prion-like protein Shadoo.

Authors:  Anna Pepe; Rosario Avolio; Danilo Swann Matassa; Franca Esposito; Lucio Nitsch; Chiara Zurzolo; Simona Paladino; Daniela Sarnataro
Journal:  Sci Rep       Date:  2017-06-16       Impact factor: 4.379

4.  Impairment of mitochondria dynamics by human A53T α-synuclein and rescue by NAP (davunetide) in a cell model for Parkinson's disease.

Authors:  T Q Melo; K C van Zomeren; M F R Ferrari; H W G M Boddeke; J C V M Copray
Journal:  Exp Brain Res       Date:  2016-11-19       Impact factor: 1.972

Review 5.  Amyloid assembly and disassembly.

Authors:  Edward Chuang; Acacia M Hori; Christina D Hesketh; James Shorter
Journal:  J Cell Sci       Date:  2018-04-13       Impact factor: 5.285

6.  Cofilin 1 promotes the pathogenicity and transmission of pathological α-synuclein in mouse models of Parkinson's disease.

Authors:  Mingmin Yan; Min Xiong; Lijun Dai; Xingyu Zhang; Yunhong Zha; Xiaorong Deng; Zhui Yu; Zhentao Zhang
Journal:  NPJ Parkinsons Dis       Date:  2022-01-10

Review 7.  The spread of prion-like proteins by lysosomes and tunneling nanotubes: Implications for neurodegenerative diseases.

Authors:  Guiliana Soraya Victoria; Chiara Zurzolo
Journal:  J Cell Biol       Date:  2017-07-19       Impact factor: 10.539

Review 8.  Attempt to Untangle the Prion-Like Misfolding Mechanism for Neurodegenerative Diseases.

Authors:  Daniela Sarnataro
Journal:  Int J Mol Sci       Date:  2018-10-09       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.